Filing Details
- Accession Number:
- 0001209191-19-058365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-27 17:07:43
- Reporting Period:
- 2019-11-26
- Accepted Time:
- 2019-11-27 17:07:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1107421 | Ziopharm Oncology Inc | ZIOP | Pharmaceutical Preparations (2834) | 841475642 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1429559 | G Kevin Lafond | C/O Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 | Svp, Treasurer & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-26 | 11,667 | $2.85 | 97,222 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-26 | 11,667 | $5.25 | 85,555 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2019-11-26 | 11,667 | $0.00 | 11,667 | $2.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-12-31 | No | 4 | M | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 30, 2019.
- Fully vested.
Billionaire Hedge Funds
